MannKind (MNKD) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts MNKD Hot Sheet
Price: $3.96 +4.21%
Revenue Growth %: +42.5%
Financial Fact:
Interest expense on senior convertible notes: -4.17M
Today's EPS Names:
CIX, FRPH, WMK, More
Revenue Growth %: +42.5%
Financial Fact:
Interest expense on senior convertible notes: -4.17M
Today's EPS Names:
CIX, FRPH, WMK, More
Join SI Premium – FREE
MannKind (NASDAQ: MNKD) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $40.62 million versus the consensus estimate of $37.41 million.
For earnings history and earnings-related data on MannKind (MNKD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pacira Pharma (PCRX) Tops Q2 EPS by 8c ; Offers Guidance
- Bristow Group (VTOL) Misses Q1 EPS by 57c; offers guidance
- Ultragenyx Pharma (RARE) Tops Q2 EPS by 32c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
